Despite expanding treatment options for rare glomerular diseases such as immunoglobulin A nephropathy (IgAN) and focal ...

Adults and adolescents with alopecia areata had nearly 8 times higher odds of near-complete scalp hair regrowth on an oral ...

SGLT2 inhibitors have outgrown their diabetes-only label, and formulary teams that still price them that way are missing the bigger cardiorenal picture entirely.

Dr. Haumschild identifies several contributors to SGLT2 inhibitor underuse, starting with fragmentation in care. He says the biggest issue is often the gap between identifying an ...

Follitropin delta (Rekovelle; Ferring), a recombinant follicle-stimulating hormone produced in a human cell line, achieved cumulative ongoing pregnancy rates of 64.0% in patients ...

Although zidesamtinib (Jideytro; GSK) was designed to be better tolerated than other ROS1 inhibitors, it can still cause adverse effects that require monitoring, and questions remain about how best to ...

The Ambulatory Specialty Model (ASM) has the potential to reduce chronic disease costs by holding specialists accountable for ...

Michael Mina, MD, PhD, of Invivyd explains how a few amino acid changes let VYD2311 move from IV to a single IM shot that ...

Quantitative computed tomography (CT) methods can help predict disease progression and assess the efficacy of drugs in ...

Fathi, of Mass General Brigham Cancer Institute, says PARADIGM trial data support azacitidine-venetoclax for ...

Delphi consensus guides dermatology on spotting CTCL vs atopic dermatitis before/after dupilumab, using biopsy plus T-cell ...

Ask about burning, stinging, and facial warmth, and use dermoscopy or diascopy to spot rosacea when redness is hard to see.